Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500110524Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial of HRS-9190 (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Proportion of subjects with excellent or good intubation conditions. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500110524.